These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969 [TBL] [Abstract][Full Text] [Related]
9. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Kirkin V; Mazitschek R; Krishnan J; Steffen A; Waltenberger J; Pepper MS; Giannis A; Sleeman JP Eur J Biochem; 2001 Nov; 268(21):5530-40. PubMed ID: 11683876 [TBL] [Abstract][Full Text] [Related]
10. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K EMBO J; 1996 Apr; 15(7):1751. PubMed ID: 8612600 [No Abstract] [Full Text] [Related]
11. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005 [TBL] [Abstract][Full Text] [Related]
12. Proteolytic processing regulates receptor specificity and activity of VEGF-C. Joukov V; Sorsa T; Kumar V; Jeltsch M; Claesson-Welsh L; Cao Y; Saksela O; Kalkkinen N; Alitalo K EMBO J; 1997 Jul; 16(13):3898-911. PubMed ID: 9233800 [TBL] [Abstract][Full Text] [Related]
13. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability. Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Lymboussaki A; Olofsson B; Eriksson U; Alitalo K Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055 [TBL] [Abstract][Full Text] [Related]
16. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Dunk C; Ahmed A Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691 [TBL] [Abstract][Full Text] [Related]
18. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Huang HY; Ho CC; Huang PH; Hsu SM Lab Invest; 2001 Dec; 81(12):1729-34. PubMed ID: 11742043 [TBL] [Abstract][Full Text] [Related]
20. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Marconcini L; Marchio S; Morbidelli L; Cartocci E; Albini A; Ziche M; Bussolino F; Oliviero S Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9671-6. PubMed ID: 10449752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]